Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elisabeth Polard

Showing results (21-30 of 68) with videos related to

Pageof 7
Sort By:
European Journal of Clinical Pharmacology|April 12, 2019
Hepatotoxicity risk factors and acetaminophen dose adjustment, do prescribers give this issue adequate consideration? A French university hospital studyAstrid Bacle, Charlotte Pronier, Helene Gilardi, et al.
Therapie|August 29, 2013
[Use of the PMSI for the detection of adverse drug reactions]Marie-Noëlle Osmont, Marc Cuggia, Elisabeth Polard, et al.
Pulmonary Pharmacology & Therapeutics|August 2, 2022
Real-world safety profiles of pirfenidone and nintedanib in idiopathic pulmonary fibrosis patientsDorine Fournier, Stéphane Jouneau, Guillaume Bouzillé, et al.
Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie|May 3, 2026
Hyperammonemia in children treated with asparaginase for acute lymphoblastic leukaemiaLéa Bonneau, Caroline Moreau, Elisabeth Polard, et al.
Journal of Neurology|January 9, 2010
3,4-diaminopyridine safety in clinical practice: an observational, retrospective cohort studyLaurent Flet, Elisabeth Polard, Olivia Guillard, et al.
Therapie|January 22, 2009
[Risperidone use in child and adolescent psychiatric patients]Claire Chevreuil, Jean-Michel Reymann, Tanya Frémaux, et al.
The American Journal of Tropical Medicine and Hygiene|December 10, 2009
Short report: Incidence of yellow fever vaccine-associated neurotropic diseaseThomas Guimard, Sophie Minjolle, Elisabeth Polard, et al.
Therapie|January 14, 2020
[Multidisciplinary meetings determining the imputability of xenobiotics in causes of death: What contribution to pharmacovigilance data?]Sébastien Lalanne, Quentin Caradec, Alain Baert, et al.
International Journal of Antimicrobial Agents|April 18, 2018
Acute kidney injury during treatment with high-dose cloxacillin: a report of 23 cases and literature reviewAurélie Lavergne, Cécile Vigneau, Elisabeth Polard, et al.
European Journal of Clinical Pharmacology|July 12, 2005
Can colchicine potentiate the anticoagulant effect of fluindione?Valérie Gras-Champel, Patrick Ohlmann, Elisabeth Polard, et al.
Pageof 7

Showing results (21-30 of 68) with videos related to

Sort By:
Pageof 7
European Journal of Clinical Pharmacology|April 12, 2019
Hepatotoxicity risk factors and acetaminophen dose adjustment, do prescribers give this issue adequate consideration? A French university hospital studyAstrid Bacle, Charlotte Pronier, Helene Gilardi, et al.
Therapie|August 29, 2013
[Use of the PMSI for the detection of adverse drug reactions]Marie-Noëlle Osmont, Marc Cuggia, Elisabeth Polard, et al.
Pulmonary Pharmacology & Therapeutics|August 2, 2022
Real-world safety profiles of pirfenidone and nintedanib in idiopathic pulmonary fibrosis patientsDorine Fournier, Stéphane Jouneau, Guillaume Bouzillé, et al.
Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie|May 3, 2026
Hyperammonemia in children treated with asparaginase for acute lymphoblastic leukaemiaLéa Bonneau, Caroline Moreau, Elisabeth Polard, et al.
Journal of Neurology|January 9, 2010
3,4-diaminopyridine safety in clinical practice: an observational, retrospective cohort studyLaurent Flet, Elisabeth Polard, Olivia Guillard, et al.
Therapie|January 22, 2009
[Risperidone use in child and adolescent psychiatric patients]Claire Chevreuil, Jean-Michel Reymann, Tanya Frémaux, et al.
The American Journal of Tropical Medicine and Hygiene|December 10, 2009
Short report: Incidence of yellow fever vaccine-associated neurotropic diseaseThomas Guimard, Sophie Minjolle, Elisabeth Polard, et al.
Therapie|January 14, 2020
[Multidisciplinary meetings determining the imputability of xenobiotics in causes of death: What contribution to pharmacovigilance data?]Sébastien Lalanne, Quentin Caradec, Alain Baert, et al.
International Journal of Antimicrobial Agents|April 18, 2018
Acute kidney injury during treatment with high-dose cloxacillin: a report of 23 cases and literature reviewAurélie Lavergne, Cécile Vigneau, Elisabeth Polard, et al.
European Journal of Clinical Pharmacology|July 12, 2005
Can colchicine potentiate the anticoagulant effect of fluindione?Valérie Gras-Champel, Patrick Ohlmann, Elisabeth Polard, et al.
Pageof 7